Evidence map›Paper›PMID 41647924›Full record

ArticleNAR genomics and bioinformatics2026

ANOMALY: a Snakemake pipeline for identifying NuMTs from long-read sequencing data.

Nirmal S Mahar, Rachit Singh, Ishaan Gupta, Shweta Ramdas

Abstract read
In one paragraph

Article in NAR genomics and bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nirmal S MaharDepartment of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi 110016, India.ORCID https://orcid.org/0000-0001-6296-0494
Rachit SinghCentre for Brain Research, Indian Institute of Science, Bangalore 560012, India.
Ishaan GuptaDepartment of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi 110016, India.
Shweta RamdasCentre for Brain Research, Indian Institute of Science, Bangalore 560012, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear mitochondrial DNA segments (NuMTs) can contribute to cancer development and disease progression by disrupting protein-coding genes. Furthermore, their presence confounds mitochondrial variant detection, underscoring the critical need for robust NuMT detection. Current methods to call NuMTs rely on short-read sequencing data but struggle to resolve complex NuMTs. These limitations can be overcome by employing long-read sequencing data. However, no such workflow exists to capture NuMTs from long-read sequencing data. Here, we introduce ANOMALY, a novel, easy-to-use workflow for detecting NuMTs from long-read sequencing data. The pipeline takes raw sequencing or aligned data and calls and visualises sample NuMTs. On 50 simulated datasets, the pipeline demonstrated high accuracy, with a precision of 1.000, a recall of 0.989, and an F1-score of 0.994. The pipeline underscores the limitations of short-read data in resolving and capturing complex NuMTs while demonstrating that long-read data enables their accurate identification. The Snakemake pipeline employs Python, Bash and R and is published under an open-source GNU GPL v3 license. Detailed information on setting up and running the pipeline, along with the source code, is available at https://github.com/Nirmal2310/ANOMALY.

Indexed as

Cell NucleusDNA, MitochondrialSequence Analysis, DNASoftwareAlgorithmsHigh-Throughput Nucleotide SequencingHumansDNA, Mitochondrial

Identifiers

PMID41647924
PMCPMC12869244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.